A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01611363
Recruitment Status : Completed
First Posted : June 5, 2012
Last Update Posted : August 22, 2017
Information provided by (Responsible Party):
Astellas Pharma Inc ( Astellas Pharma Europe B.V. )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 3, 2012
  Actual Study Completion Date : February 3, 2012